Vaccine immunogenicity assessed by HI assay - per protocol population.
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://figshare.com/articles/dataset/_Vaccine_immunogenicity_assessed_by_HI_assay_per_protocol_population_/774671
下载链接
链接失效反馈官方服务：
资源简介：
1n/N: responders (n) as proportion of the (sub-)population (N).
2GMT: geometric mean titer;
395% CI: 95% confidence interval.
4Seroprotection rate: proportion of subjects with a protective titer pre- or post-vaccination (titer ≥40).
5Seroconversion rate: proportion of subjects with antibody increase from <10 pre-vaccination to ≥40 post-vaccination.
6Significant increase: proportion of subjects with an antibody titer of ≥10 pre-vaccination and 4-fold antibody increase post-vaccination.
7CHMP criteria.
8GM increase = geometric mean increase.
创建时间：
2013-08-16
